Datasets:

Haxirus

/

Fine-Tuning_Dataset

like 0

Does Abciximab and Estrone sulfate interact?

Estrogens activate the coagulation pathway via increasing plasma fibrinogen and the activity of coagulation factors such as factors VII and X. Co-administration of estrogens with anticoagulant agents may interfere with the anticoagulant actions of those agents. In short, Estrone sulfate may decrease the anticoagulant activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Estrone interact?

Therapeutic immune globulins have been associated with the risk for adverse thromboembolic events, oftentimes leading to withdrawal from therapy. The use of estrogen-containing preparations, such as oral contraceptives (OC), is also a well established risk factor for venous thrombosis. Co-administration of two agents may further elevate the risk for developing thrombotic disorders. In short, Estrone may increase the thrombogenic activities of Abciximab, and the severity of the interaction is minor.

Does Abciximab and Ethinylestradiol interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Ethynodiol diacetate interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Ethynodiol diacetate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Etodolac interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Etonogestrel interact?

Systemic hormonal contraceptives, such as the subject drug, are known to increase the risk of venous thromboembolism (VTE).4,1,3 While specific data regarding the concomitant use of hormonal contraceptives and anticoagulants is sparse, it follows that the procoagulant effects of hormonal contraceptives may oppose the therapeutic effects of anticoagulants, lowering their efficacy and increasing the risk of clotting. The estrogen component of combined hormonal contraceptives appears to the be the primary culprit in their induction of hypercoagulability - its effects appear to be driven by alterations to procoagulant proteins (i.e. clotting factors) and an induced resistance to activated protein C (APC), an endogenous anticoagulant. While it was previously thought that first-pass metabolism of oral contraceptives through the liver was responsible for their prothrombotic effect, more recent studies have suggested that alternative routes of administration (i.e. routes that bypass first-pass metabolism) do not improve the risk of clotting, and this is reflected in the FDA labeling for these non-oral contraceptive options. Progestin-only contraceptives do not appear to carry the same risk of thrombotic events as do estrogen-containing contraceptives. This interaction is likely to be more significant in patients with other risk factors for hormonal contraceptive-induced thrombotic events, such as smoking, age >35, obesity, and hypertension. In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Etonogestrel, and the severity of the interaction is moderate.

Does Abciximab and Etoposide interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Etoposide, and the severity of the interaction is minor.

Does Abciximab and Etoricoxib interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Everolimus interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus, and the severity of the interaction is minor.

Does Abciximab and Evolocumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Evolocumab, and the severity of the interaction is minor.

Does Abciximab and Factor IX Complex (Human) interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Factor XIII (human) interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Fenoprofen interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Fibrinogen human interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Floctafenine interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Floxuridine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Floxuridine, and the severity of the interaction is minor.

Does Abciximab and Flucytosine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Flucytosine, and the severity of the interaction is minor.

Does Abciximab and Fludarabine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Fludarabine, and the severity of the interaction is minor.

Does Abciximab and Fluorouracil interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil, and the severity of the interaction is minor.

Does Abciximab and Fluoxetine interact?

It has been reported that concomitant administration of antiplatelet agents and SSRI is associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Flurbiprofen interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Fluvoxamine interact?

It has been reported that concomitant administration of antiplatelet agents and SSRI is associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Fondaparinux interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Fondaparinux, and the severity of the interaction is moderate.

Does Abciximab and Fremanezumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Fremanezumab, and the severity of the interaction is minor.

Does Abciximab and Galcanezumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab, and the severity of the interaction is minor.

Does Abciximab and Gemcitabine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine, and the severity of the interaction is minor.

Does Abciximab and Gemtuzumab ozogamicin interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Gemtuzumab ozogamicin, and the severity of the interaction is minor.

Does Abciximab and Ginkgo biloba interact?

Cases of bleeding, including serious bleeding events, have occurred with ginkgo biloba.4 Key constituents of ginkgo biloba, such as flavones and terpene lactones, were shown to possess anticoagulant and antiplatelet activities. For example, ginkgolide B displaces platelet-activating factor (PAF) from its binding sites, decreasing blood coagulation. A strong causal relationship between ginkgo biloba use and anticoagulant effects has not been established, and some evidence suggests that the short-term use of ginkgo might not significantly lead to anticoagulant effects. Additionally, drug interaction studies looking at the relationship between ginkgo biloba and anticoagulant agents were not conducted; however, concurrent administration of anticoagulants with ginkgo may present an additional risk of bleeding. In short, Ginkgo biloba may increase the anticoagulant activities of Abciximab, and the severity of the interaction is minor.

Does Abciximab and Glofitamab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Glofitamab, and the severity of the interaction is minor.

Does Abciximab and Glucosamine interact?

Several studies suggest that glucosamine may increase antiplatelet effects.3,1,2 When combined with antiplatelet drugs, the additive antiplatelet effects of glucosamine and drugs that inhibit platelet activity or function may increase the risk of bleeding In short, Glucosamine may increase the antiplatelet activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Golimumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab, and the severity of the interaction is minor.

Does Abciximab and Guselkumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab, and the severity of the interaction is minor.

Does Abciximab and Hemin interact?

Various studies have found that hemin is capable of demonstrating an anticoagulant effect [31427, 31428, 31429] as well as evidence of bleeding [31428, 31329] in patients administered the medication. Since an anticoagulant effect is also principal to the action of anticoagulant medications, concomitant use with hemin is not recommended because of the risk of enhancing the anticoagulant effect that is shared between hemin and other anticoagulant medications and therefore increasing the chances for dangerous bleeding events. In short, Hemin may increase the anticoagulant activities of Abciximab, and the severity of the interaction is major.

Does Abciximab and Heparin interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Heparin, and the severity of the interaction is moderate.

Does Abciximab and Hepatitis B immune globulin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Hepatitis B immune globulin, and the severity of the interaction is minor.

Does Abciximab and Human cytomegalovirus immune globulin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin, and the severity of the interaction is minor.

Does Abciximab and Human immunoglobulin G interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab, and the severity of the interaction is minor.

Does Abciximab and Human Rho(D) immune globulin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Human Rho(D) immune globulin, and the severity of the interaction is minor.

Does Abciximab and Human varicella-zoster immune globulin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Human varicella-zoster immune globulin, and the severity of the interaction is minor.

Does Abciximab and Hydrochlorothiazide interact?

The efficacy of oral anticoagulants may be reduced by the concomitant use of thiazide diuretics.2 The evidence for this interaction is conflicting.1 In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydrochlorothiazide, and the severity of the interaction is minor.

Does Abciximab and Hydroflumethiazide interact?

The efficacy of oral anticoagulants may be reduced by the concomitant use of thiazide diuretics.2 The evidence for this interaction is conflicting.1 In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydroflumethiazide, and the severity of the interaction is minor.

Does Abciximab and Hydroxyprogesterone caproate interact?

Systemic hormonal contraceptives, such as the subject drug, are known to increase the risk of venous thromboembolism (VTE).4,1,3 While specific data regarding the concomitant use of hormonal contraceptives and anticoagulants is sparse, it follows that the procoagulant effects of hormonal contraceptives may oppose the therapeutic effects of anticoagulants, lowering their efficacy and increasing the risk of clotting. The estrogen component of combined hormonal contraceptives appears to the be the primary culprit in their induction of hypercoagulability - its effects appear to be driven by alterations to procoagulant proteins (i.e. clotting factors) and an induced resistance to activated protein C (APC), an endogenous anticoagulant. While it was previously thought that first-pass metabolism of oral contraceptives through the liver was responsible for their prothrombotic effect, more recent studies have suggested that alternative routes of administration (i.e. routes that bypass first-pass metabolism) do not improve the risk of clotting, and this is reflected in the FDA labeling for these non-oral contraceptive options. Progestin-only contraceptives do not appear to carry the same risk of thrombotic events as do estrogen-containing contraceptives. This interaction is likely to be more significant in patients with other risk factors for hormonal contraceptive-induced thrombotic events, such as smoking, age >35, obesity, and hypertension. In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydroxyprogesterone caproate, and the severity of the interaction is moderate.

Does Abciximab and Hydroxyurea interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea, and the severity of the interaction is minor.

Does Abciximab and Ibalizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ibalizumab, and the severity of the interaction is minor.

Does Abciximab and Ibritumomab tiuxetan interact?

Antiplatelet agents may agents exert an additive effect on the anticoagulant actions of ibritumomab tiuxetan, which may cause bleeding or thrombocytopenia. This increases the risk of bleeding complications due to thrombocytopenia. In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ibritumomab tiuxetan, and the severity of the interaction is moderate.

Does Abciximab and Ibrutinib interact?

Fatal bleeding events and grade 3 or higher bleeding events including subdural hematoma, gastrointestinal bleeding, hematuria and post procedural hemorrhage have been observed with ibrutinib therapy. Bleeding events of any grade, including bruising and petechiae, occurred in approximately half of patients treated with ibrutinib. While the mechanism for the bleeding events of ibrutinib is not clearly understood, co-adminsitereing ibrutininb with drugs with potential to cause bleeding, such as anticoagulants, may increase the risk for non-fatal or fatal bleeding and hemorrhage. In short, The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Abciximab, and the severity of the interaction is minor.

Does Abciximab and Ibuprofen interact?

Concomitant use of antiplatelet and non-steroidal anti-inflammatory agents (NSAIDs) is associated with increased risk of gastrointestinal bleeding. In short, The risk or severity of bleeding can be increased when Ibuprofen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Icosapent ethyl interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Icosapent interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Idarubicin interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin, and the severity of the interaction is minor.

Does Abciximab and Idarucizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Idarucizumab, and the severity of the interaction is minor.

Does Abciximab and Ifosfamide interact?

It is reported that ifosfamide, due to its mechanism of action, can produce a significant reduction in the platelet number generating severe thrombocytopenia. This effect can derive from a high risk of bleeding events. When this agent is combined with anticoagulant agents, there is a high risk of bleeding events that can be very severe. In short, The risk or severity of bleeding can be increased when Ifosfamide is combined with Abciximab, and the severity of the interaction is major.

Does Abciximab and Iloprost interact?

Since iloprost inhibits platelet function, there is a potential for increased risk of bleeding, particularly in patients maintained on anticoagulants or platelet inhibitors. In short, Iloprost may increase the anticoagulant activities of Abciximab, and the severity of the interaction is minor.

Does Abciximab and Imatinib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Imatinib, and the severity of the interaction is minor.

Does Abciximab and Imdevimab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Imdevimab, and the severity of the interaction is minor.

Does Abciximab and Imlifidase interact?

Imlifidase cleaves IgG antibodies and may therefore inactivate monoclonal antibodies derived from human or rabbit IgG if given concomitantly.1 However, when given at therapeutic doses, imlifidase does not appear to cleave eculizumab. In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Imlifidase, and the severity of the interaction is moderate.

Does Abciximab and Indomethacin interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Inebilizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Inebilizumab, and the severity of the interaction is minor.

Does Abciximab and Infliximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Infliximab, and the severity of the interaction is minor.

Does Abciximab and Inotersen interact?

Since inotersen can cause a reduction in platelet count, the risk of thrombocytopenia can be increased when used in combination with other antiplatelet agents. In short, The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Inotuzumab ozogamicin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Inotuzumab ozogamicin, and the severity of the interaction is minor.

Does Abciximab and Interferon alfa-2a interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, and the severity of the interaction is minor.

Does Abciximab and Interferon alfa-2b interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2b, and the severity of the interaction is minor.

Does Abciximab and Interferon alfa-n3 interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3, and the severity of the interaction is minor.

Does Abciximab and Interferon beta-1b interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Interferon beta-1b, and the severity of the interaction is minor.

Does Abciximab and Interferon gamma-1b interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b, and the severity of the interaction is minor.

Does Abciximab and Ipilimumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ipilimumab, and the severity of the interaction is minor.

Does Abciximab and Irinotecan interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Irinotecan, and the severity of the interaction is minor.

Does Abciximab and Isatuximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Isatuximab, and the severity of the interaction is minor.

Does Abciximab and Isocarboxazid interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Ixabepilone interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Ixabepilone, and the severity of the interaction is minor.

Does Abciximab and Ixekizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ixekizumab, and the severity of the interaction is minor.

Does Abciximab and Ketoprofen interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Ketorolac interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Lanadelumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Lanadelumab, and the severity of the interaction is minor.

Does Abciximab and Lebrikizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Lebrikizumab, and the severity of the interaction is minor.

Does Abciximab and Lecanemab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Lecanemab, and the severity of the interaction is minor.

Does Abciximab and Lenalidomide interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Lenalidomide, and the severity of the interaction is minor.

Does Abciximab and Levocarnitine interact?

It is reported that L-carnitine can decrease different blood coagulation factors such as fibrinogen, Factor VII, fibrin degradation products, and plasminogen activator inhibitor-1 as well as the platelet aggregation. This effect can produce an increase in the anticoagulation functions of other anticoagulants like warfarin. This interaction can actually be used to decrease hypercoagulation states in diabetes patients and to decrease inflammation factors while helping regulate the coagulation state In short, The therapeutic efficacy of Abciximab can be increased when used in combination with Levocarnitine, and the severity of the interaction is minor.

Does Abciximab and Levomilnacipran interact?

Drugs that inhibit serotonin reuptake, such as levomilnacipran, interfere with platelet function by affecting the release of serotonin by platelets and may result in an increased risk of bleeding. Concomitant use of levomilnacipran with the subject drug, an antiplatelet agent, may potentiate the risk of bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Levomilnacipran, and the severity of the interaction is minor.

Does Abciximab and Levonorgestrel interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Linezolid interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Lomustine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Lomustine, and the severity of the interaction is minor.

Does Abciximab and Loncastuximab tesirine interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Loncastuximab tesirine, and the severity of the interaction is minor.

Does Abciximab and Lornoxicam interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Loxoprofen interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Lynestrenol interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Lynestrenol is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Margetuximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Margetuximab, and the severity of the interaction is minor.

Does Abciximab and Mechlorethamine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Mechlorethamine, and the severity of the interaction is minor.

Does Abciximab and Meclofenamic acid interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Medroxyprogesterone acetate interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Medroxyprogesterone acetate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Mefenamic acid interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Megestrol acetate interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Meloxicam interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Melphalan interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Melphalan, and the severity of the interaction is minor.

Does Abciximab and Mepolizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab, and the severity of the interaction is minor.

Does Abciximab and Mercaptopurine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Mercaptopurine, and the severity of the interaction is minor.

Does Abciximab and Mesalazine interact?

.Concurrent use of salicylates and anticoagulants may lead to increased anticoagulant activity and therefore an increased risk of bleeding, due to additive anticoagulant effects. In short, The risk or severity of bleeding can be increased when Mesalazine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Methimazole interact?

Due to potential inhibition of vitamin K activity by methimazole and other antithyroid agents, the activity of anticoagulants (for example, warfarin) may be increased. The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to methimazole and other antithyroid medications. In short, Methimazole may increase the anticoagulant activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Methotrexate interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Methotrexate, and the severity of the interaction is minor.